Multi-scale study of normal aging predicts novel late-onset Alzheimer's disease risk variants by unknown
POSTER PRESENTATION Open Access
Multi-scale study of normal aging predicts novel
late-onset Alzheimer’s disease risk variants
Sarah M Neuner1, Lynda Wilmott1, Matthew DeBoth2, Thomas Shapaker1, Jesse Ingels3, Lu Lu3, Rob Williams3,
Gerd Kempermann4, Matthew Huentelman2, Catherine C Kaczorowski1*
From 14th Annual UT-KBRIN Bioinformatics Summit 2015
Buchanan, TN, USA. 20-22 March 2015
Background
Alzheimer’s disease (AD) is a neurodegenerative disor-
der characterized by severe memory impairment and
accumulation of neuropathological amyloid plaques and
tau tangles. By contrast, ‘normal’ age-associated cogni-
tive decline is less severe and generally occurs in the
absence of neuropathology. Many believe aging- and
AD-related memory impairments result from separate
etiologies, but this distinction is not entirely consistent
with emerging evidence that both are linked to hippo-
campal dysfunction. As aging is the most significant risk
factor for late-onset AD (LOAD), we hypothesize that
memory deficits in both ‘normal’ aging and AD are dri-
ven in part by some common underlying mechanisms,
which are exacerbated in AD by disease-specific insults
such as neurodegeneration, neuroinflammation, and
neuropathologies. In addition, heritability estimates sug-
gest a strong genetic component (50-80%) in both con-
ditions [1,2]. Thus, elucidating genetic correlates of
memory decline in ‘normal’ aging may identify risk fac-
tors that influence susceptibility to LOAD.
Materials and methods
Given that genetically diverse mouse models have
emerged as a powerful way to study complex human
traits, we conducted a multi-scalar analysis of two inde-
pendent mouse models of aging to test this hypothesis
[3]. We combined memory tests with proteomic, tran-
scriptomic, and genomic data to generate a list of the top
30 candidates that correlate with memory impairments.
To evaluate the translational potential of these candi-
dates, we performed secondary analysis using published
hippocampal transcript data from LOAD patients relative
to age-matched non-demented controls [4].
Results
Eighteen genes including TRPC3, GABRA3, GABRA5,
GABRB1, GABRB2, WDFY3, and GRM1 were signifi-
cantly differentially expressed relative to disease status,
suggesting they may play a role in the human disease
process. In addition, we wanted to identify whether any
of our candidate genes contained single nucleotide poly-
morphisms (SNPs) that could be used to predict an indi-
vidual’s susceptibility to LOAD. To test the ability of our
multi-scalar approach to detect known LOAD risk genes,
we searched our full dataset for published risk genes. We
identified APOE, SORL1, EPHA1, BIN1, and TREM2 as
significantly differentially expressed relative to memory
function in our aging models, validating our approach.
We then tested our novel candidates against the freely
available ADGC “TGEN2” dataset that is a clinical char-
acterized and neuropathologically verified cohort [5,6].
Our analysis yielded four nominally significant novel
putative risk variants (GABRB1, GABRB2, GRM1, and
WDFY3) using data generated by our study of aging
models.
Conclusions
Future work will investigate functional significance of
these SNPs and validate mechanistic relevance to cognitive
decline during aging and AD. This work demonstrates the
utility of studying ‘normal’ aging models to both better
understand molecular mechanisms mediating memory
function in diverse populations and to identify those can-
didates with the best potential to translate into effective
treatments and predictive biomarkers for cognitive decline
in elderly humans.
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